Buckeye Cruise for Cancer


The annual Buckeye Cruise for Cancer sets sail each year with a ship full of Buckeye Greats and fans in support of the Urban and Shelley Meyer Fund for Cancer Research at the OSUCCC – James. This fund is dedicated to the recruitment of cancer research experts to The James, so that we continue to have the best and brightest minds at Ohio State.

2014 Buckeye Cruise: A Grand Success

Thank you to all of the cruisers and supporters who made the 2014 Buckeye Cruise for Cancer such a success. More than $1 million was raised for the Urban and Shelley Meyer Fund for Cancer Research and the Buckeye Cruise for Cancer.

Get on Board for 2015

Join us February 19 – 23, 2015, on the Buckeye Cruise to help fight cancer. We will be sailing on Royal Caribbean's Brilliance of the Seas out of Tampa and will stop at Cozumel this year! Cozumel has many exciting excursions to choose from.

Proceeds from the Buckeye Cruise for Cancer benefit the Urban and Shelley Meyer Fund for Cancer Research ((link to Meyer Fund page)) at the OSUCCC – James. To learn more and to book your cabin today, please visit www.buckeyecruise.com or call Travel Partners Specialty Tours at 614-792-0002.

Contact Us

OSUCCC – James Development Office

Phone

614-293-3752

Email

annualgiving@osumc.edu

By Mail

660 Ackerman Road, 6th Floor
PO Box 183112
Columbus, OH 43218-3112

Latest News

Prostate Cancer Androgen Receptor Activates a Different Gene Set When Bound to Antiandrogens

The androgen receptor in prostate cancer cells can activate different sets of genes depending on whether it binds with an androgen hormone or an antiandrogen drug, according to a new study led by...

Read More

Individualizing Treatments for Multiple Myeloma

This week on Toward a Cancer-Free World, Dr. Craig Hofmeister shares how using an actual virus to help treat certain blood cancer patients may just get us even closer to a cancer-free world.

Read More

Generating New Hope Through Pelotonia-Funded Research

Pelotonia funds support cancer drug development projects at Ohio State. Here’s a brief look at a basic-science study of a targeted agent that may improve cancer-killing virus therapy, and two clinical...

Read More

Upcoming Events

View More